Microvascular Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Microvascular Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-06Clinical Trial Update: Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
A clinical trial investigating the association between microvascular disease by PET and graft injury via donor-derived cell-free DNA has bee…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function
A completed study evaluates how cardiac diastolic function and coronary microvascular function relate to prognosis in ischemic heart disease…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) [NA]
A clinical trial registry entry for the CATCH-EM study evaluating empagliflozin's impact on myocardial blood flow in asymptomatic adults wit…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment [NA]
Clinical trial update comparing two administration pathways for adenosine during microvascular function assessment; the study is not yet rec…
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction [Phase 2, Phase 3]
Phase 2/3 clinical trial update investigating reversal of microvascular dysfunction in heart failure with preserved ejection fraction.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-04-08Clinical Trial Update: Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. [Phase 3]
Phase 3 study in diabetes patients undergoing PCI was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI [Phase 2]
Phase 2 dose titration study evaluating SAR407899 in patients with microvascular coronary artery disease; the trial was terminated with resu…